- Home
- FRGT vs MBIO Comparison
FRGT vs MBIO Comparison
Compare FRGT & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGT
- MBIO
- Stock Information
- Founded
- FRGT 2015
- MBIO 2015
- Country
- FRGT Mexico
- MBIO United States
- Employees
- FRGT N/A
- MBIO N/A
- Industry
- FRGT Professional Services
- MBIO Biotechnology: Pharmaceutical Preparations
- Sector
- FRGT Consumer Discretionary
- MBIO Health Care
- Exchange
- FRGT Nasdaq
- MBIO Nasdaq
- Market Cap
- FRGT 4.2M
- MBIO 4.7M
- IPO Year
- FRGT N/A
- MBIO N/A
- Fundamental
- Price
- FRGT $1.20
- MBIO $1.65
- Analyst Decision
- FRGT
- MBIO
- Analyst Count
- FRGT 0
- MBIO 0
- Target Price
- FRGT N/A
- MBIO N/A
- AVG Volume (30 Days)
- FRGT 76.6K
- MBIO 178.7K
- Earning Date
- FRGT 08-18-2025
- MBIO 08-08-2025
- Dividend Yield
- FRGT N/A
- MBIO N/A
- EPS Growth
- FRGT N/A
- MBIO N/A
- EPS
- FRGT N/A
- MBIO N/A
- Revenue
- FRGT $12,693,870.00
- MBIO N/A
- Revenue This Year
- FRGT $371.03
- MBIO N/A
- Revenue Next Year
- FRGT N/A
- MBIO N/A
- P/E Ratio
- FRGT N/A
- MBIO N/A
- Revenue Growth
- FRGT N/A
- MBIO N/A
- 52 Week Low
- FRGT $1.15
- MBIO $0.89
- 52 Week High
- FRGT $23.31
- MBIO $21.95
- Technical
- Relative Strength Index (RSI)
- FRGT 23.66
- MBIO 46.95
- Support Level
- FRGT $1.15
- MBIO $1.56
- Resistance Level
- FRGT $1.58
- MBIO $1.88
- Average True Range (ATR)
- FRGT 0.10
- MBIO 0.15
- MACD
- FRGT -0.01
- MBIO -0.00
- Stochastic Oscillator
- FRGT 8.33
- MBIO 51.06
About FRGT Freight Technologies Inc.
Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.